NexGel Inc
Last updated September 27, 2026
Organization details
- Legal name
- NexGel Inc
- Former names
- AquaMed Technologies, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Langhorne
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NXGL
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001468929
- EIN
- 26-4042544
Board of directors
-
Adam R. Levy · Director · Chief Executive OfficerSince 2024
-
Brian Joseph Kieser · DirectorSince 2026
-
David Stefansky · DirectorSince 2023
-
Jerome B. Zeldis · DirectorSince 2023
-
John Nachum Stein · DirectorSince 2023
-
Kevin McClain Harris · DirectorSince 2026
-
Miranda Jayne Toledano · DirectorSince 2023
-
Scott Robert Henry · DirectorSince 2023
-
Steven Ciardiello · DirectorSince 2025
-
Steven Mark Glassman · DirectorSince 2023
Chief executives
Adam R. Levy
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 17, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.1%
-
96.9%
-
100.0%
-
100.0%
Board connections
2 of this board's directors also sit on 4 other boards.
- via Miranda Jayne Toledano
- via Miranda Jayne Toledano
- via Jerome B. Zeldis
- via Jerome B. Zeldis
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $77,289
- 16 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −5,000 | $0.59 | $2,950 |
| Jun 18, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −6,000 | $0.59 | $3,540 |
| Jun 11, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −3,000 | $0.61 | $1,830 |
| Jun 8, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −3,000 | $0.55 | $1,650 |
| Jun 4, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −3,000 | $0.59 | $1,770 |
| Jun 1, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −2,000 | $0.59 | $1,180 |
| May 29, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −3,000 | $0.60 | $1,800 |
| May 28, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −7,000 | $0.61 | $4,270 |
| May 27, 2026 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −3,000 | $0.60 | $1,800 |
| Dec 24, 2025 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −4,000 | $1.57 | $6,280 |
| Dec 22, 2025 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −6,000 | $1.61 | $9,660 |
| Nov 6, 2025 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −4,000 | $2.52 | $10,080 |
| Oct 3, 2025 | Scott Robert Henry Director | Open-market sale | −7,175 | $2.55 | $18,296 |
| Oct 3, 2025 | Adam R. Levy Director, Officer (Chief Executive Officer) | Open-market sale | −2,400 | $2.55 | $6,120 |
| Oct 2, 2025 | Scott Robert Henry Director | Open-market sale | −825 | $2.50 | $2,063 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.